Humacyte (NASDAQ:HUMA) announced that its Phase 3 V012 study met its primary superiority endpoint, showing the company’s acellular tissue engineered vessel (ATEV) significantly reduces time spent on dialysis catheters.
TuHURA Biosciences (NASDAQ:HURA) announced today that it has submitted an Investigational New Drug application to the U.S. Food and Drug Administration to advance its TBS-2025 therapy.
Paranovus Entertainment Technology (NASDAQ:PAVS) executed a non-binding letter of intent to acquire Jabanero for a proposed all-cash purchase price of $15 million to $20 million.
Jerash Holdings (NASDAQ:JRSH) reported record full-year fiscal 2026 revenue of $166.3 million following a 46.6% surge in fourth-quarter sales.
Alkermes plc (NASDAQ:ALKS) announced that its investigational oral medication, alixorexton, was granted orphan drug designations by regulatory authorities in the United States and Europe for rare sleep disorders.
IREN (NASDAQ:IREN), a leading vertically integrated AI Cloud infrastructure provider, today announced the formal completion of its acquisition of Ingenostrum, S.L., widely known as Nostrum Group.
Coda Octopus Group (NASDAQ:CODA) reported its fiscal second-quarter 2026 financial results for the period ended April 30, 2026.
Tripadvisor (NASDAQ:TRIP) executed a put option agreement to sell its European online restaurant reservation and management platform, TheFork, to American Express (NYSE:AXP) for $700 million in cash.
Generac Holdings (NYSE:GNRC) has finalized the acquisition of a new manufacturing facility in Belvidere, Illinois.
Honeywell (NASDAQ:HON) has greenlit a structural corporate split, separating its high-performing aerospace operations from its automation and software assets.
GARANTA JÁ SEU GRAFA EDGE
Sign up free to unlock this feature
Vamos ativar um teste de 30 dias do Edge como presente de boas-vindas
-640x360.webp&w=3840&q=75)
